Cephalosporin derivatives

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

540226, 540227, C07D50136

Patent

active

053327314

ABSTRACT:
A new class of cephalosporin derivatives is provided, which is useful as antibacterial agent to be particularly suitable for oral administrations in mammals including man, and which is represented by general formula (I) ##STR1## wherein R.sup.1 is a hydrogen atom or a lower alkyl group; R.sup.2 is a hydrogen atom or an ester-forming group capable of being cleaved easily with an esterase existing in the digestive tracts; n is an integer of zero or 1; Z is a saturated heterocyclic group containing one or two oxygen atoms as the hetero-atoms with or without one or more lower alkyl substituents, or a pharmaceutically acceptable salt thereof.

REFERENCES:
patent: 4256739 (1981-03-01), Woodward et al.
patent: 4729991 (1988-03-01), Veda et al.
patent: 4760060 (1988-07-01), Mochida et al.
patent: 4812562 (1989-03-01), Watanabe et al.
patent: 5239068 (1993-08-01), Blaszczak et al.
patent: 5246926 (1993-09-01), Bateson et al.
Chemical Abstracts vol. 115:182946m (1992).
Chem. Abstracts, 1991, vol. 114, No. 3, Jan. 21, 1991.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Cephalosporin derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cephalosporin derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cephalosporin derivatives will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1053349

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.